NWBO

Northwest Biotherapeutics, Inc. Common stock
NWBO

Overview Fund Activity
Delisted

NWBO was delisted on the 16th of December, 2016.

Back to rankings

14 hedge funds and large institutions have $633K invested in Northwest Biotherapeutics, Inc. Common stock in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.

Holders
14
Holders Change
-1
Holders Change %
-6.67%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
4
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AA
1
Ancora Advisors
Ohio
$313K
2
CAPTRUST Financial Advisors
2
CAPTRUST Financial Advisors
North Carolina
$11K
3
OCG
3
Opus Capital Group
Ohio
$35K
4
MSAM
4
Moloney Securities Asset Management
Missouri
$179K

Top Sellers

1
KA
1
Kovack Advisors
Florida
$0
2
ECM
2
Estabrook Capital Management
New York
$4.41K
Name Market Value Shares Shares
Change 		Shares
Change %
AA
1
Ancora Advisors
Ohio
$313K 497,000 +120,850 +32%
MSAM
2
Moloney Securities Asset Management
Missouri
$179K 284,460 +5,995 +2%
OCG
3
Opus Capital Group
Ohio
$35K 55,150 +10,000 +22%
WJWM
4
Williams Jones Wealth Management
New York
$25K 39,000 – –
GWI
5
Grace & White Inc
New York
$16K 25,305 – –
AIP
6
Almanack Investment Partners
Pennsylvania
$14K 22,000 – –
LDB
7
Lee, Danner & Bass
Tennessee
$13K 20,000 – –
CAPTRUST Financial Advisors
8
CAPTRUST Financial Advisors
North Carolina
$11K 17,624 +11,334 +180%
AA
9
AlphaMark Advisors
Kentucky
$9K 14,007 – –
GG
10
Gofen & Glossberg
Illinois
$8K 12,740 – –
ECM
11
Estabrook Capital Management
New York
$4.41K 7,000 -3,000 -30%
BC
12
Bartlett & Co
Ohio
$3K 4,292 – –
BCWM
13
Bartlett & Co Wealth Management
Ohio
$2.7K 4,292 – –
KA
14
Kovack Advisors
Florida
– – -10,000 Closed
HFS
15
Hantz Financial Services
Michigan
$0 250 – –